Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 7 to 17

Extended‑release sodium oxybate for children with narcolepsy type 1

Official title: Safety, Convenience, and Tolerability of a Nightly Single Oral Dose of Extended-release Sodium Oxybate in Children

Run by Stanford University · NCT06809803 · Data updated 2026-11-12

This will test whether an extended‑release form of sodium oxybate is safer, more convenient, and preferred by children with narcolepsy type 1 compared with non‑extended‑release oxybate options.

Quick facts

PhasePhase 2
Study typeInterventional
Ages7 Years to 17 Years
SexAll
Enrollment36 (estimated)
SponsorStanford University
Academic / other
Locations1 site (Redwood City, California)
StatusRecruiting
StartedOctober 27, 2025
Main results expectedJune 2027
Study endsJuly 2027
Registry record updatedNovember 6, 2025
Trial IDNCT06809803 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children with a documented diagnosis of narcolepsy type 1 who are under the care of the Stanford Sleep Clinic, are on stable medications, and whose parent/guardian provides consent and the child agrees to participate.

Probably not a fit

Patients with uncontrolled mental health or sleep disorders causing sleepiness, current suicidal thoughts or severe depression, active illegal drug use, or current pregnancy are excluded and unlikely to benefit from joining this trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 2 interventional trial enrolls children with documented narcolepsy type 1 who are followed at the Stanford Sleep Clinic to compare extended‑release sodium oxybate with non‑extended‑release oxybates. Participants will receive the two treatment approaches and researchers will collect data on patient and parent treatment preference, safety, tolerability, convenience, and symptom response. The trial requires informed parental/guardian consent and stable background medications during participation. Safety monitoring and standardized measures of narcolepsy symptoms and tolerability will be used to compare outcomes between the formulations.

Why it matters

Potential benefit: If successful, the extended‑release option could offer children a more convenient and better tolerated oxybate choice that works as well as current formulations.

How similar studies have gone: Immediate‑release sodium oxybate is an established treatment for narcolepsy and extended‑release formulations have shown positive results in adults, but pediatric data are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Participants must be under the care of a doctor at the Stanford Sleep Clinic.
2. Participants must have a documented diagnosis of narcolepsy type 1 shown by sleepiness and either: a spinal fluid marker for narcolepsy (hypocretin-1) at a specific level, or a history of sudden loss of muscle control (cataplexy), or a particular genetic marker for narcolepsy, or a sleep study showing a specific sleep pattern for narcolepsy.
3. Parent(s), or guardian(s) have signed a consent form and the child must agree to participate.
4. Participants are on a stable dose of medications

Exclusion Criteria:

Participants who have any of the following conditions will not be included in the study

1. Uncontrolled mental health problems
2. Uncontrolled sleep problems that lead to sleepiness.
3. Currently having thought about ending one's life or sadness or loss of interest
4. Currently having a problem with illegal drug use
5. Currently pregnant

Where it's running

  • Stanford University
    Redwood City, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Diet changes to reduce sleepiness in narcolepsy and idiopathic hypersomnia

    This project will try whether a 12-week whole-food ketogenic diet versus an isocaloric standard whole-food diet reduces daytime sleepiness and improves quality of life in adults with narcolepsy or idiopathic hypersomnia.

    Recruiting University of Sydney · Macquarie Park, New South Wales · NCT07006233

  • A digital tool to help decide about an ICD

    We’re testing a patient-friendly online aid to help people with advanced heart failure decide whether an implantable cardioverter-defibrillator (ICD) is right for them.

    Recruiting at 2 sites Stanford University · San Francisco, California and 1 other locations · NCT07913204

  • Wise Interventions to Boost Pediatric Weight Control

    This study tests whether adding two quick social-psychology activities (growth mindset and self-affirmation) to a family-based weight management program helps 10–15 year-olds with obesity achieve better BMI outcomes over 12 months.

    Recruiting Stanford University · Stanford, California · NCT07839832

  • Reducing Chronic Pain After Cesarean Delivery

    A single-session pain-relief class called Empowered Relief is tested alongside standard postpartum care to see if it helps women who have ongoing pain after cesarean delivery.

    Recruiting Stanford University · Palo Alto, California · NCT07799883

  • Human-created animated art vs AI-created art: does it change how you feel right away?

    This online trial tests whether watching a human-made animated art film or an AI-made one, or doing nothing, quickly changes mood or sense of connection in U.S. adults.

    Recruiting Stanford University · Palo Alto, California and 1 other locations · NCT07740148

  • SMILE in one eye vs Ray tracing-guided LASIK in the fellow eye

    This study tests two laser vision correction methods—SMILE in one eye and ray-tracing guided LASIK in the other eye—to see which provides better vision and quality of life for adults with myopia and astigmatism.

    Recruiting Phase 4 Stanford University · Palo Alto, California · NCT07721714

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.